|
GO:0042981—regulation of apoptotic process |
6.04E-05 |
RASSF5, TNFRSF11B, DUSP1, NTF3, FYN, GDF5, ESR1 |
|
GO:0032148—activation of protein kinase B activity |
7.76E-05 |
WNT5A, NTF3, FGF1, NRG1 |
|
GO:0007596—blood coagulation |
3.06E-04 |
PRKAR2B, FYN, GATA6, ITGA2, PDGFD, PLAU |
|
GO:0071560—cellular response to transforming growth factor beta stimulus |
5.22E-04 |
WNT5A, FYN, SOX5, PDGFD |
|
GO:0043066—negative regulation of apoptotic process |
6.03E-04 |
WNT5A, EDNRB, DUSP1, RPS6KA1, ID1, GATA6, FOXO1, PIK3R1 |
|
GO:0045944—positive regulation of transcription from RNA polymerase II promoter |
1.01E-03 |
KLF5, WNT5A, RPS6KA1, GATA6, HIPK2, TFEB, ESR1, FOXO1, FGF1, NRG1, PIK3R1 |
|
GO:0045893—positive regulation of transcription, DNA-templated |
1.25E-03 |
KLF5, WNT5A, GATA6, HIPK2, TFEB, ESR1, FOXO1, LGR4 |
|
GO:0018108—peptidyl-tyrosine phosphorylation |
1.47E-03 |
EPHA4, FYN, FGF1, NRG1, EPHA2 |
|
GO:0014066—regulation of phosphatidylinositol 3-kinase signaling |
2.02E-03 |
FYN, FGF1, NRG1, PIK3R1 |
|
GO:0030335—positive regulation of cell migration |
2.88E-03 |
NTF3, PDGFD, FGF1, PIK3R1, PLAU |
|
GO:0046854—phosphatidylinositol phosphorylation |
3.43E-03 |
FYN, FGF1, NRG1, PIK3R1 |
|
GO:0030182—neuron differentiation |
3.53E-03 |
WNT5A, ID1, HIPK2, EPHA2 |
|
GO:0008284—positive regulation of cell proliferation |
3.70E-03 |
KLF5, EDNRB, NTF3, HIPK2, PDGFD, FGF1, NRG1 |
|
GO:0048015—phosphatidylinositol-mediated signaling |
4.80E-03 |
FYN, FGF1, NRG1, PIK3R1 |
|
GO:0000187—activation of MAPK activity |
4.93E-03 |
WNT5A, NTF3, FGF1, NRG1 |
|
GO:0045892—negative regulation of transcription, DNA-templated |
5.16E-03 |
WNT5A, ID1, GATA6, FOXO1, NRG1, ZBTB18, LGR4 |
|
GO:0045766—positive regulation of angiogenesis |
6.02E-03 |
WNT5A, GATA6, HIPK2, FGF1 |
|
GO:0000122—negative regulation of transcription from RNA polymerase II promoter |
7.94E-03 |
KLF5, EDNRB, ID1, GATA6, HIPK2, ESR1, FOXO1, ZBTB18 |
|
GO:0043524—negative regulation of neuron apoptotic process |
8.79E-03 |
NTF3, FYN, GDF5, HIPK2 |
|
GO:0035556—intracellular signal transduction |
9.37E-03 |
PRKAR2B, RASSF5, DUSP1, RPS6KA1, FYN, NRG1 |
|
GO:0045213—neurotransmitter receptor metabolic process |
9.62E-03 |
DMD, NRG1 |
|
GO:0060750—epithelial cell proliferation involved in mammary gland duct elongation |
1.28E-02 |
WNT5A, ESR1 |
|
GO:0048146—positive regulation of fibroblast proliferation |
1.31E-02 |
WNT5A, ESR1, PDGFD |
|
GO:0043406—positive regulation of MAP kinase activity |
1.54E-02 |
PDE5A, PDGFD, FGF1 |
|
GO:0043627—response to estrogen |
1.86E-02 |
TNFRSF11B, GATA6, ESR1 |
|
GO:0014068—positive regulation of phosphatidylinositol 3-kinase signaling |
1.86E-02 |
FYN, PDGFD, NRG1 |
|
GO:0048841—regulation of axon extension involved in axon guidance |
2.23E-02 |
PLXNA4, PLXNA2 |
|
GO:0008366—axon ensheathment |
2.23E-02 |
NRG1, MBP |
|
GO:0050966—detection of mechanical stimulus involved in sensory perception of pain |
2.54E-02 |
FYN, ITGA2 |
|
GO:0008286—insulin receptor signaling pathway |
2.61E-02 |
PDK4, FOXO1, PIK3R1 |
|
GO:0090630—activation of GTPase activity |
2.67E-02 |
WNT5A, NTF3, EPHA2 |
|
GO:0060068—vagina development |
2.89E-02 |
WNT5A, ESR1 |
|
GO:0021785—branchiomotor neuron axon guidance |
2.86E-02 |
PLXNA4, PLXNA2 |
|
GO:0007165—signal transduction |
3.11E-02 |
TNFRSF11B, NTF3, RPS6KA1, PDE5A, NR3C2, ESR1, FGF1, PIK3R1, PLAU |
|
GO:0048013—ephrin receptor signaling pathway |
3.12E-02 |
EPHA4, FYN, EPHA2 |
|
GO:0031643—positive regulation of myelination |
3.17E-02 |
WASF3, NRG1 |
|
GO:0010976—positive regulation of neuron projection development |
3.33E-02 |
WNT5A, FYN, DMD |
|
GO:1901653—cellular response to peptide |
3.48E-02 |
KLF5, ID1 |
|
GO:0046849—bone remodeling |
3.48E-02 |
LGR4, EPHA2 |
|
GO:0033628—regulation of cell adhesion mediated by integrin |
3.48E-02 |
EPHA2, PLAU |
|
GO:0001525—angiogenesis |
3.49E-02 |
KLF5, PTPRB, ID1, FGF1 |
|
GO:0007179—transforming growth factor beta receptor signaling pathway |
3.53E-02 |
ID1, GDF5, HIPK2 |
|
GO:0008584—male gonad development |
3.68E-02 |
WNT5A, GATA6, ESR1 |
|
GO:1902287—semaphorin-plexin signaling pathway involved in axon guidance |
3.79E-02 |
PLXNA4, PLXNA2 |
|
GO:0055119—relaxation of cardiac muscle |
3.79E-02 |
RGS2, PDE5A |
|
GO:0007169—transmembrane receptor protein tyrosine kinase signaling pathway |
3.82E-02 |
NTF3, FYN, NRG1 |
|
GO:0001678—cellular glucose homeostasis |
4.41E-02 |
FOXO1, PIK3R1 |
|
GO:0060065—uterus development |
4.41E-02 |
WNT5A, ESR1 |
|
GO:0006636—unsaturated fatty acid biosynthetic process |
4.72E-02 |
ELOVL2, SCD5 |
